accessible online at http://www.cdc.gov/nchs/nhds.htm . All diagnoses are based on ICD-9-CM codes. Data Collection Data collected and analyzed included age, sex, race, admission type (urgent/emergent vs elective), hospital characteristics, LOS
Search Results
Trends in the Incidence and Outcomes of Hospitalized Cancer Patients With Clostridium difficile Infection: A Nationwide Analysis
Arjun Gupta, Raseen Tariq, Ryan D. Frank, Gary W. Jean, Muhammad S. Beg, Darrell S. Pardi, David H. Johnson, and Sahil Khanna
Comparison of Treatment Strategies for Patients With Clinical Stage T1–3/N2 Lung Cancer
Ya-Fu Cheng, Wei-Heng Hung, Heng-Chung Chen, Ching-Yuan Cheng, Ching-Hsiung Lin, Sheng-Hao Lin, and Bing-Yen Wang
excluded if they received no therapy or if their database records were missing values for therapy or type of surgery. Baseline patient demographics (age and sex), tumor characteristics (histologic grade, cell type, T stage), and treatment details (surgery
Relationship Between Perceptions of Treatment Goals and Psychological Distress in Patients With Advanced Cancer
Areej El-Jawahri, Deborah Forst, Alyssa Fenech, Keri O. Brenner, Amanda L. Jankowski, Lauren Waldman, Isabella Sereno, Ryan Nipp, Joseph A. Greer, Lara Traeger, Vicki Jackson, and Jennifer Temel
, relationship status, or time since diagnosis of incurable cancer and patient-reported QoL or mood. Table 1. Participant Characteristics Patients’ Perceptions of Both Their Treatment Goal and Their Oncologist’s Goal Figure 1 depicts patients’ perceptions of
Impact of Provider Imaging Practices on Survival Outcomes in Advanced Ovarian Cancer
Angela K. Green, Deborah Korenstein, Carol Aghajanian, Brooke Barrow, Michael Curry, and Roisin E. O’Cearbhaill
patients who underwent SCS by imaging practices. Characteristics between patients treated by high- versus low-frequency imaging providers were compared using chi-square tests for discrete variables and t tests for continuous variables. Because CA-125
Intravenous Patient-Controlled Analgesia Versus Oral Opioid to Maintain Analgesia for Severe Cancer Pain: A Randomized Phase II Trial
Rongbo Lin, Jinfeng Zhu, Yushuang Luo, Xia Lv, Mingqian Lu, Haihui Chen, Huichao Zou, Zhichun Zhang, Shaowei Lin, Milu Wu, Xiaofeng Li, Min Zhou, Shen Zhao, Liyu Su, Jiang Liu, and Cheng Huang
or avNRS among the 3 arms ( Table 1 ). Other baseline characteristics were well balanced between the 3 groups, with comparable ESAS symptom severity ( supplemental eTable 2 and Table 1 ). Figure 1. Study profile. (A1) Bolus-only arm, (A2
Neuroendocrine Tumors
Matthew H. Kulke, Al B. Benson III, Emily Bergsland, Jordan D. Berlin, Lawrence S. Blaszkowsky, Michael A. Choti, Orlo H. Clark, Gerard M. Doherty, James Eason, Lyska Emerson, Paul F. Engstrom, Whitney S. Goldner, Martin J. Heslin, Fouad Kandeel, Pamela L. Kunz, Boris W. Kuvshinoff II, Jeffrey F. Moley, Venu G. Pillarisetty, Leonard Saltz, David E. Schteingart, Manisha H. Shah, Stephen Shibata, Jonathan R. Strosberg, Jean-Nicolas Vauthey, Rebekah White, James C. Yao, Deborah A. Freedman-Cass, and Mary A. Dwyer
< 5% of patients) are not specifically discussed in these guidelines. Histologic Classification and Staging of Neuroendocrine Tumors Neuroendocrine tumors are generally subclassified by site of origin and histologic characteristics. Pancreatic
Impact of Facility Surgical Volume on Survival in Patients With Cancer
Kelsey C. Stoltzfus, Biyi Shen, Leila Tchelebi, Daniel M. Trifiletti, Niraj J. Gusani, Vonn Walter, Ming Wang, and Nicholas G. Zaorsky
insurance (51.6%), and had stage 0–III disease (64.8%). Patients traveled an average of 30.9 miles to get to their treatment facility. These results are summarized in Table 1 . Table 1. Patient Characteristics Surgical facility volume
Comparison of Cancer Burden and Nonprofit Organization Funding Reveals Disparities in Funding Across Cancer Types
Suneel D. Kamath, Sheetal M. Kircher, and Al B. Benson III
amount of annual revenue supporting each cancer type. Table 1. Characteristics of Nonprofit Organizations Among cancer type–specific NPOs, the cancers with the largest number of organizations were breast cancer (13; 22%), pediatric cancers (13; 22
Carcinosarcomas (Malignant Mixed Müllerian Tumor) of the Uterus: Advances in Elucidation of Biologic and Clinical Characteristics
Lauren E. Kernochan and Rochelle L. Garcia
Edited by Kerrin G. Robinson
Carcinosarcoma of the uterus (malignant mixed Müllerian tumor [MMMT]) is an uncommon, typically extremely aggressive neoplasm histologically composed of malignant epithelial and mesenchymal (stromal) elements. Although the literature contains some debate, most authors now agree that most MMMTs derive from sarcomatous differentiation in a high-grade carcinoma. This article reviews the clinical and histopathologic features of this interesting neoplasm, with particular emphasis on recent data supporting MMMTs as primarily epithelial malignant neoplasms with areas of mesenchymal/spindle cell differentiation.